B. A. Howard and B. A. Gusterson (2000). Human breast development. J. Mammary Gland Biol. Neoplasia
J. M. Veltmaat, A. A. Mailleux, J. P. Thiery, and S. Bellusci (2003). Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation
L. Hennighausen, and G. W. Robinson (1998). Think globally, act locally: The making of a mouse mammary gland. Genes Dev.
R. D. Cardiff and S. R. Wellings (1999). The comparative pathology of human and mouse mammary glands. J. Mammary Gland Biol. Neoplasia
M. J. Wheelock, A. P. Soler, and K. A. Knudsen (2001). Cadherin junctions in mammary tumors. J. Mammary Gland Biol. Neoplasia
J. M. Daniel and A. B. Reynolds (1997). Tyrosine phosphorylation and cadherin/catenin function. Bioessays
D. Nanba, Y. Nakanishi, and Y. Hieda (2001). Changes in adhesive properties of epithelial cells during early morphogenesis of the mammary gland. Dev. Growth Differ.
C. W. Daniel, P. Strickland, and Y. Friedmann (1995). Expression and functional role of E-and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev. Biol.
G. L. Radice, M. C. Ferreira-Cornwell, S. D. Robinson, H. Rayburn, L. A. Chodosh, M. Takeichi, and R. O. Hynes (1997). Precocious mammary gland development in P-cadherin-deficient mice. J. Cell Biol.
V. Delmas, P. Pla, H. Feracci, J. P. Thiery, R. Kemler, and L. Larue (1999). Expression of the cytoplasmic domain of E-cadherin induces precocious mammary epithelial alveolar formation and affects cell polarity and cell-matrix integrity. Dev. Biol.
O. Boussadia, S. Kutsch, A. Hierholzer, V. Delmas, and R. Kemler (2002). E-cadherin is a survival factor for the lactating mouse mammary gland. J. Mech. Dev.
G. Berx, F. Nollet, and F. van Roy (1998). Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes. Commun.
G. L. Bratthauer, F. Moinfar, M. D. Stamtakos, T. Mezzetti, K. M. Shekitka, Y. G. Man, and F. A. Tavassoli (2002). Combined E-Cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal and hybrid mammary intraepithelial neoplasias. Hum. Pathol.
S. Hirohashi (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol.
J. P. Thiery (2002). Epithelial-mesnchymal transitions in tumour progression. Nat. Rev. Cancer
A. S. Wong and B. M. Gumbiner (2003). Adhesion-Independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol.
N. Fujita, D. L. Jaye, M. Kajita, and C. Geigerman (2003). MoreNuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell
M. J. Blanco, G. Moreno-Bueno, D. Sarrio, A. Locascio, A. Cano, J. Palacios, and M. A. Nieto (2002). Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene
K. M. Hajra and E. R. Fearon (2002). Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer
K. Yoshiura, Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, and S. Hirohashi (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. U.S.A.
S. Koizume, K. Tachibana, T. Sekiya, S. Hirohashi, and M. Shiraishi (2002). Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res.
L. M. Billard, F. Magdinier, G. M. Lenoir, L. Frappart, and R. Dante (2002). MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene
A. Herrera-Gayol and S. Jothy (1999). Adhesion proteins in the biology of breast cancer: Contribution of CD44. Exp. Mol. Pathol.
Y. Xu and Q. Yu (2003). E-cadherin negatively regulates CD44-hyaluron interaction and CD44-mediated tumor invasion and branching morphogenesis. J. Biol. Chem.
R. H. Giles, J. H. van Es, and H. Clevers (2003). Caught up in a storm: Wnt signaling in cancer. Biochim. Biophys. Acta.
X. He (2003). A wnt-wnt situation. Dev. Cell
M. Bienz and H. Clevers (2003). Armadillo/beta-catenin signals in the nucleus-proof beyond a reasonable doubt? Nat. Cell Biol.
F. J. Staal, M. Noort Mv, G. J. Strous, and H. C. Clevers (2002). Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep.
D. H. Song, I. Dominguez, J. Mizuno, M. Kaut, S. C. Mohr, and D. C. Seldin (2003). CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. J. Biol. Chem.
D. Wolf, M. Rodova, E. A. Miska, J. P. Calvet, and T. Kouzarides (2002). Acetylation of beta-catenin by CREB-binding protein (CBP). J. Biol. Chem.
K. I. Takemaru and R. T. Moon (2000). The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. Cell Biol.
N. Barker, A. Hurlstone, H. Musisi, A. Miles, M. Bienz, and H. Clevers (2001). The chromatin remodeling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J.
B. Thompson, F. Townsley, R. Rosin-Arbesfeld, H. Musisi, and M. Bienz (2002). A new nuclear component of the Wnt signaling pathway. Nat. Cell Biol.
T. Y. Belenkaya, C. Han, H. J. Standley, X. Lin, D. W. Houston, J. Heasman, and X. Lin (2002). Pygopus encodes a nuclear protein essential for wingless/Wnt signaling. Development
T. Kramps, O. Peter, E. Brunner, D. Nellen, B. Froesch, S. Chatterjee, M. Murone, S. Zullig, and K. Basler (2002). Wnt/ wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell
A. M. Brown (2001). Wnt signaling in breast cancer: Have we come full circle? Breast. Cancer Res.
L. R. Howe, O. Watanabe, J. Leonard, and A. M. Brown (2003). Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res.
E. J. Gunther, S. E. Moody, G. K. Belka, K. T. Hann, N. Innocent, K. D. Dugan, R. D. Cardiff, and L. A. Chodosh (2003). Impact of p53 on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev.
C. M. Alexander, F. Reichsman, M. T. Hinkes, J. Lincecum, K. A. Becker, S. Cumberledge, and M. Bernfield (2000). Syndecan-1 is required for Wnt-1 induced mammary tumorigenesis in mice. Nat. Genet.
W. Hsu, R. Shakya, and F. Costantini (2001). Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J. Cell Biol.
C. Genderen, R. M. Okamura, I. Farinas, R. G. Quo, T. G. Parslow, L. Bruhn, and R. Grosschedl (1994). Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev.
J. Roose, G. Huls, M. van Beest, P. Moerer, K. van der Horn, R. Goldschmeding, T. Logtenberg, and H. Clevers (1999). Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science
R. C. Gallagher, T. Hay, V. Meniel, C. Naughton, T. J. Anderson, H. Shibata, M. Ito, H. Clevers, T. Noda, O. J. Sansom, J. O. Mason, and A. R. Clarke (2002). Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene
M. Kashiwaba, G. Tamura, and M. Ishida (1994). Aberrations of the APC gene in primary breast carcinoma. J. Cancer Res. Clin. Oncol.
A. Thompson, R. Morris, M. Wallace, A. Wyllie, C. Steel, and D. Carter (1993). Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br. J. Cancer
K. Ho, W. Kalle, T. H. S. Lo, W. Lam, and C. Tang (1999). Reduced expression of APC and DCC gene protein in breast cancer. Histopathology
P. Schlosshauer, S. Brown, K. Eisenger, Q. Yan, E. Guglielminetti, R. Parsons, L. Ellenson, and J. Kitajewski (2000). APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis
T. Woodage, S. King, S. Wacholder, P. Hartge, J. Struewing, M. McAdams, S. J. Laken, M. A. Tucker, and L. C. Brody (1998). The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat. Genet.
K. Furuuchi, M. Tada, H. Yamada, A. Kataoka, N. Furuuchi, J. Hamada, M. Takahashi, S. Todo, T. Moriuchi (2000). Somatic mutations of the APC gene in primary breast cancers. Am. J. Pathol.
Z. Jin, G. Tamura, T. Tsuchiya, K. Sakata, M. Kashiwaba, M. Osakabe, and T. Motoyama (2001). Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br. J. Cancer
T. Nagahata, T. Shimada, A. Harada, H. Nagai, M. Onda, S. Yokoyama, T. Shiba, E. Jin, O. Kawanami, and M. Emi (2003). Amplification, up regulation and overexpression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci.
M. K. El-Tanani, R. Barraclough, M. C. Wilkinson, and P. S. Rudland (2001). Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene
J. S. Michaelson and P. Leder (2001). Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene
A. Imbert, R. Eelkema, S. Jordan, H. Feiner, and P. Cowin (2001). Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol.
A. Ryo, M. Nakamura, G. Wulf, Y. C. Liou, and K. P. Lu (2001). Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol.
Q. Yu, Y. Geng, and P. Sicinski (2001). Specific protection against breast cancers by cyclin D1 ablation. Nature
E. Sadot, B. Geiger, M. Oren, and A. Ben-Ze'ev (2001). Down-regulation of beta-catenin by activated p53. Mol. Cell Biol.
T. Cagatay and M. Ozturk (2002). P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene
M. Ueda, R. M. Gemmill, J. West, R. Winn, M. Sugita, N. Tanaka, M. Ueki, H. A. Drabkin (2001). Mutations of the beta-and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br. J. Cancer
H. Huang, H. Fujii, A. Sankila, B. M. Mahler-Araujo, M. Matsuda, G. Cathomas, and H. Ohgaki (1999). Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 155: 1795–1801.
S. Satoh, Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Nishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Yamaoka, and Y. Nakamura (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet.
S. Hirohashi and Y. Kanai (2003). Cell adhesion system and human cancer morphogenesis. Cancer Sci.
G. Berx, and F. Van Roy (2001). The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast. Cancer Res.
C. J. Gottardi, E. Wong, and B. M. Gumbiner (2001). E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. Cell Biol.
J. Castano, I. Raurell, J. A. Piedra, S. Miravet, M. Dunach, and A. Garcia de Herreros (2002). Beta-catenin N-and C-terminal tails modulate the coordinated binding of adherens junction proteins to beta-catenin. J. Biol. Chem.
A. H. Huber and W. I. Weis (2001). The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell
J. Klingelhofer, R. B. Troyanovsky, O. Y. Laur, and S. Troyanovsky (2003). Exchange of catenins in cadherin-catenin complex. Oncogene
A. M. Carothers, K. A. Melstrom, Jr., J. D. Mueller, M. J. Weyant, and M. M. Bertagnolli (2001). Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J. Biol. Chem.
M. Bienz (1999). APC: The plot thickens. Curr. Opin. Genet. Dev.
C. J. Vallorosi, K. C. Day, X. Zhao, M. G. Rashid, M. A. Rubin, K. R. Johnson, M. J. Wheelock, and M. L. Day (2000). Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. Biol. Chem.
J. Rios-Doria, K. C. Day, R. Kuefer, M. G. Rashid, A. M. Chinnaiyan, M. A. Rubin, and M. L. Day (2003). The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J. Biol. Chem.
M. Serres, O. Filhol, H. Lickert, C. Grangeasse, E. M. Chambaz, J. Stappert, C. Vincent, and D. Schmitt (2000). The disruption of adherens junctions is associated with a decrease of E-cadherin phosphorylation by protein kinase CK2. Exp. Cell Res.
H. Lickert, A. Bauer, R. Kemler, and J. Stappert (2000). Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J. Biol. Chem.
S. Bek and R. Kemler (2002). Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J. Cell Sci.
M. S. Kinch, G. J. Clark, C. J. Der, and K. Burridge (1995). Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J. Cell Biol.
T. Muller, A. Choidas, E. Reichmann, and A. Ullrich (1999). Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem.
Y. Kanai, A. Ochiai, T. Shibata, T. Oyama, S. Ushijima, S. Akimoto, and S. Hirohashi (1995). c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. Biochem. Biophys. Res. Commun.
T. Shibata, A. Ochiai, Y. Kanai, S. Akimoto, M. Gotoh, N. Yasui, R. Machinami, and S. Hirohashi (1996). Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. Oncogene
K. L. Carraway, V. P. Ramsauer, B. Haq, and C. A. Carothers (2003). Cell signaling through membrane mucins. Bioessays
S. J. Gendler (2001). MUC1, The renaissance molecule. J. Mammary Gland Biol. Neoplasia
J. A. Schroeder, M. C. Adriance, M. C. Thompson, T. D. Camenisch, and S. J. Gendler (2003). MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene
M. L. Taddei, P. Chiarugi, P. Cirri, F. Buricchi, T. Fiaschi, E. Giannoni, D. Talini, G. Cozzi, L. Formigli, G. Raugei, and G. Ramponi (2002). Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res.
C. Jamora, R. DasGupta, P. Kocieniewski, and E. Fuchs (2003). Links between signal transduction, transcription and adhesion in epithelial bud development. Nature